CAROLYN J LOGAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CAROLYN J LOGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CAROLYN J LOGAN. CAROLYN J LOGAN is President & CEO in SALIX PHARMACEUTICALS LTD ($SLXP).
Latest Insider Trading Transactions of CAROLYN J LOGAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 17.63 | 44,000 | 775,720 | 0 | |
| Dec 23 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 17.63 | 44,000 | 775,720 | 703,838 | 659.8 K to 703.8 K (+6.67 %) |
| Aug 26 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 158.30 | 46,684 | 7,390,077 | 659,838 | 613.2 K to 659.8 K (+7.61 %) |
| Jul 03 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 123.35 | 8,253 | 1,018,008 | 613,154 | 621.4 K to 613.2 K (-1.33 %) |
| Jun 30 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 18.87 | 65,625 | 1,238,344 | 0 | |
| Jun 30 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 18.87 | 33,750 | 636,863 | 0 | |
| Jun 30 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 122.38 | 1,000 | 122,380 | 621,407 | 622.4 K to 621.4 K (-0.16 %) |
| Jun 30 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 123.13 | 32,857 | 4,045,682 | 622,407 | 655.3 K to 622.4 K (-5.01 %) |
| Jun 30 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 123.87 | 19,200 | 2,378,304 | 655,264 | 674.5 K to 655.3 K (-2.85 %) |
| Jun 30 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 18.87 | 65,625 | 1,238,344 | 674,464 | 608.8 K to 674.5 K (+10.78 %) |
| Jun 30 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 18.87 | 33,750 | 636,863 | 608,839 | 575.1 K to 608.8 K (+5.87 %) |
| Apr 21 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 100.66 | 73,684 | 7,417,031 | 575,089 | 501.4 K to 575.1 K (+14.70 %) |
| Feb 19 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 400,000 | 0 | 400,000 | 0 to 400 K |
| Feb 19 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 400,000 | 0 | 501,405 | 901.4 K to 501.4 K (-44.38 %) |
| Jan 06 2014 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 89.94 | 34,055 | 3,062,907 | 901,405 | 935.5 K to 901.4 K (-3.64 %) |
| Jul 03 2013 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 66.15 | 20,113 | 1,330,475 | 935,460 | 955.6 K to 935.5 K (-2.10 %) |
| Jun 24 2013 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 247,761 | 0 | 955,573 | 707.8 K to 955.6 K (+35.00 %) |
| Jun 24 2013 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 400,000 | 0 | 0 | 400 K to 0 (-100.00 %) |
| Apr 22 2013 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 48.70 | 94,199 | 4,587,491 | 707,812 | 613.6 K to 707.8 K (+15.35 %) |
| Jan 04 2013 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 40.47 | 22,268 | 901,186 | 613,613 | 635.9 K to 613.6 K (-3.50 %) |
| Dec 21 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 7.60 | 33,750 | 256,500 | 0 | |
| Dec 21 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 42.27 | 25,000 | 1,056,673 | 635,881 | 660.9 K to 635.9 K (-3.78 %) |
| Dec 21 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 7.60 | 33,750 | 256,500 | 660,881 | 627.1 K to 660.9 K (+5.38 %) |
| Jul 05 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 54.44 | 17,357 | 944,915 | 627,131 | 644.5 K to 627.1 K (-2.69 %) |
| Jul 02 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 4.07 | 228,467 | 929,861 | 0 | |
| Jul 02 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 52.07 | 119,300 | 6,211,832 | 644,488 | 763.8 K to 644.5 K (-15.62 %) |
| Jul 02 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 4.07 | 228,467 | 929,861 | 763,788 | 535.3 K to 763.8 K (+42.68 %) |
| Jun 18 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 4.07 | 36,534 | 148,693 | 228,466 | |
| Jun 18 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 4.07 | 36,534 | 148,693 | 535,321 | 498.8 K to 535.3 K (+7.32 %) |
| Apr 27 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 85,054 | 0 | 498,787 | 413.7 K to 498.8 K (+20.56 %) |
| Apr 13 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 4.07 | 20,000 | 81,400 | 265,000 | |
| Apr 13 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 4.07 | 20,000 | 81,400 | 413,733 | 393.7 K to 413.7 K (+5.08 %) |
| Jan 05 2012 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 47.85 | 9,734 | 465,772 | 393,733 | 403.5 K to 393.7 K (-2.41 %) |
| Sep 16 2011 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 450 | 0 | 4,220 | 3.8 K to 4.2 K (+11.94 %) |
| Sep 16 2011 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 450 | 0 | 4,220 | 3.8 K to 4.2 K (+11.94 %) |
| Sep 16 2011 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 450 | 0 | 403,467 | 403.9 K to 403.5 K (-0.11 %) |
| Sep 16 2011 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 450 | 0 | 403,917 | 404.4 K to 403.9 K (-0.11 %) |
Page: 1